Incretin therapy is indicated in type 2 diabetics who have not achieved glycemic control on metformin, sufonylurea, or both.

Question

Quizplus · Accepted Answer

Incretin therapy, which includes GLP-1 receptor agonists, is often considered for type 2 diabetes patients who have not achieved glycemic control with metformin and/or sulfonylureas, as it helps lower blood sugar levels by enhancing the effects of incretin hormones.

Incretin Therapy Is Indicated in Type 2 Diabetics Who Have